Acrivon Therapeutics (ACRV) Insider Trading & Ownership $5.78 +0.23 (+4.05%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Acrivon Therapeutics (NASDAQ:ACRV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$20.00 MNumber OfInsiders Selling(Last 12 Months)0 Get ACRV Insider Trade Alerts Want to know when executives and insiders are buying or selling Acrivon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACRV Insider Buying and Selling by Quarter Acrivon Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/11/2024Perceptive Advisors LlcMajor ShareholderBuy2,353,000$8.50$20,000,500.00 (Data available from 1/1/2013 forward) ACRV Insider Trading Activity - Frequently Asked Questions Who is on Acrivon Therapeutics's Insider Roster? The list of insiders at Acrivon Therapeutics includes Ltd Chione, Perceptive Advisors Llc, and Ra Capital Management, L.P.. Learn more on insiders at ACRV. What percentage of Acrivon Therapeutics stock is owned by insiders? 8.50% of Acrivon Therapeutics stock is owned by insiders. Learn more on ACRV's insider holdings. Which Acrivon Therapeutics insiders have been buying company stock? The following insider purchased ACRV shares in the last 24 months: Perceptive Advisors Llc ($20,000,500.00). How much insider buying is happening at Acrivon Therapeutics? Insiders have purchased a total of 2,353,000 ACRV shares in the last 24 months for a total of $20,000,500.00 bought. Which Acrivon Therapeutics insiders have been selling company stock? The following insider sold ACRV shares in the last 24 months: Ltd Chione ($35,718.97). How much insider selling is happening at Acrivon Therapeutics? Insiders have sold a total of 2,909 Acrivon Therapeutics shares in the last 24 months for a total of $35,718.97 sold. Acrivon Therapeutics Key ExecutivesDr. Peter Blume-Jensen M.D. (Age 61)Ph.D., Co-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer Compensation: $977.7kMs. Kristina Masson M.B.A. (Age 43)Ph.D., Co-Founder, Executive VP of Business Operations, Site Head, Treasurer, Secretary & Director Compensation: $739.78kMs. Mary-Alice Miller J.D. (Age 50)Chief Legal Officer Compensation: $587.11kMr. Rasmus Holm-Jorgensen (Age 52)Chief Financial Officer Compensation: $1MDr. Eric J. Devroe Ph.D. (Age 45)Chief Operating Officer Compensation: $614.78kMs. Katharine Peterson CPAVice President of Finance & AccountingDr. Adam D. Levy M.B.A.Ph.D., Senior VP and Head of Investor Relations & Corporate AffairsMr. Bruce CloseVice President of Quality & ComplianceMs. Parvin MiahVP & Head of Human ResourcesDr. Erick Gamelin M.D. (Age 66)Ph.D., Chief Development Officer Compensation: $480.72k More Insider Trading Tools from MarketBeat Related Companies DNA Insider Ownership LENZ Insider Ownership PLRX Insider Ownership VERV Insider Ownership BCAX Insider Ownership CRGX Insider Ownership DNTH Insider Ownership KURA Insider Ownership TECX Insider Ownership IMNM Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NASDAQ:ACRV) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acrivon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
